Reminder: April Comm Convo TOMORROW


Hi!

Biopharma already had a trust problem before the new administration.

Now, with direction and decision-making being so-called streamlined and centralized at HHS, it seems the public’s trust in healthcare – the governing bodies, scientific and medical advances, and the industry as a whole – is plummeting.

How does this chaotic landscape factor into how we do our job as communicators?

How does the absence of trust hinder our ability to fulfill our role?

How do we build trust with executives, clients, or other key stakeholders who see communications as a “nice to have” rather than a strategic function?

You’ll have your own thoughts about the answers to those questions, and in tomorrow’s Comm Convo – The Trust Exchange – you’ll hear how Kris Baum (former FDA, CDER), Mary Kosinski (FleishmanHillard), and Sarah Spencer (Vor Bio) feel about the current state of trust in the biopharma industry.

Sign up here

T2B Pro & Student members (FREE): Log in to your account, and get your promo code here.

T2B Basic members ($40): RSVP and secure your place here.

What you can expect

With perspectives from in-house, agency partner, and government, this session will open a practical discussion about strengthening the relationships that matter most, both inside and outside your organization, so that you can:

  • Lead conversations with C-suite executives that establish communications as a strategic function, even when time and attention are limited.
  • Build credibility with technical teams and research leaders by asking the right questions and surfacing the information you need.
  • Guide your communications team in creating and maintaining trust across diverse functions and audiences, especially during times of transition.
  • Strengthen our profession’s role as trusted counsel through sharper strategies for relationship-building with stakeholders across the healthcare and biopharma ecosystem.

Trust goes both ways. From talking to many of our T2B community members, we know that in the current climate, you’re also struggling to decipher what information is reputable and which organizations you can trust. You’ve asked us if we still have hope for the industry, and if so, where we’re getting it from.

The answer is that we do. We believe that together, we can get past this turbulent time and build trusting professional relationships with all key stakeholders. We’ll tell you “how” tomorrow!

Lynnea


P.S: Tickets to all of our events (both online and in-person) are included as part of the T2B Pro membership. If you plan to attend many of these sessions, becoming a T2B Pro member for $1,000 per year is better value than buying individual a la carte tickets.


T2B Monthly

Read more from T2B Monthly

Hi! The outcomes of the annual American Society of Clinical Oncology (ASCO) meeting will flood the media landscape with clinical updates, milestone announcements, and analyst notes. So biopharma comms pros and storytellers must understand how to stand out during one of healthcare’s most concentrated news moments. Enter the Q2 Media Minds Panel: Oncology Reporting and ASCO Coverage. “Top-Tier Perspective on ASCO and Beyond: How to Stand Out During Concentrated News Moments” is happening...

Hi! Last week, the T2B community tackled the topic of trust. In an intriguing and very candid Comm Convo led by speakers Kris Baum (former FDA, CDER), Mary Kosinski (FleishmanHillard), and Sarah Spencer (Vor Bio), we explored how the relationships we build shape our ability to lead, influence, and respond. With so many specific anecdotes and practical tips shared, it was hard to narrow down to just 10 key takeaways, but we managed it (barely!): Leverage science as your trust anchor. When...

Hi! We’re all about bringing together the most creative minds in biopharma in a bid to secure and enhance the future of our profession. One of the many ways we do this is through our roundtables, which are driven directly by members who specialize in, and are passionate about, key areas of biopharma communications. And the next discipline on that roster is patient advocacy and engagement. Everything you need to know about the Patient Advocacy and Engagement Roundtable This roundtable will...